NEOPLASM METASTASIS
Clinical trials for NEOPLASM METASTASIS explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM METASTASIS trials appear
Sign up with your email to follow new studies for NEOPLASM METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo strategy takes on Hard-to-Treat breast cancer
Disease control Not yet recruitingThis phase 2 trial tests whether alternating two targeted chemotherapy drugs—sacituzumab govitecan and trastuzumab deruxtecan—can help people with HER2-low triple-negative breast cancer that has spread. About 260 participants will be randomly assigned to receive either the altern…
Matched conditions: NEOPLASM METASTASIS
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Real-World data may reveal Pluvicto's true impact on advanced prostate cancer survival
Disease control Not yet recruitingThis study looks at how effective the drug Pluvicto (177Lu-PSMA-617) is in treating men with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to other parts of the body. Researchers will analyze medical records from over 1,000 patients …
Matched conditions: NEOPLASM METASTASIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Inhaled mRNA therapy takes on solid tumors in first human trial
Disease control Not yet recruitingThis early-phase study tests an inhaled mRNA immunotherapy for adults with advanced lung cancer or solid tumors that have spread to the lungs. The treatment is given as a dry powder through an inhaler. The main goal is to check safety and find the best dose, with 60 participants …
Matched conditions: NEOPLASM METASTASIS
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC